PRIMARY MYELOFIBROSIS, POST-ET AND POST-PV MYELOFIBROSIS HAVE DISTINCT CLINICAL PROFILES AND SYMPTOMATIC BURDENS : AN ANALYSIS BY THE MPN QUALITY OF LIFE INTERNATIONAL STUDY GROUP (MPN-QOL ISG)
Holly L. Geyer(Mayo Clinic Hospital), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Lydia Roy(Centre Hospitalier Universitaire de Poitiers), Francesco Passamonti(University of Milan), Frank Stegelmann(University Hospital Ulm), Pablo Muxí(Hospital Británico), Zhijian Xiao(Institute of Hematology & Blood Diseases Hospital), Gunnar Birgegård(Uppsala University Hospital), Jean‐Christophe Ianotto(Inserm), Heike L. Pahl(University Medical Center Freiburg), Federico Sackman(Fundación para la Investigación, Docencia y Prevención del Cáncer), Dolores Hernández‐Maraver(Centre Hospitalier Universitaire de Grenoble), Andreas Reiter(Heidelberg University), Thomas Lehmann(University of Basel), Deepti Radia(St Thomas' Hospital), Maria Luisa Ferrari(University of Bergamo), Norman Maldonado(University of Puerto Rico System), Heidi Kosiorek(Mayo Clinic in Florida), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), P. Zhang, F. Boyer, Y. Zhang, Konstanze Döhner(University Hospital Ulm), Björn Andréasson(NU Hospital Group), Alessandro Rambaldi(Ospedale Papa Giovanni XXIII), Jessica Samuelsson(Karolinska Institutet), Peter A.W. te Boekhorst(Erasmus MC), K. Jean-Jacques, C. Besses(Hospital Del Mar), Tiziano Barbui(University of Bergamo), Gabriel Étienne(Institut Bergonié), Dana Ranta(Centre Hospitalier Régional et Universitaire de Nancy), K. Klauke, Petter Johansson, Sonja Zweegman(Vrije Universiteit Amsterdam), R. Scherber, Xiao Sun(Soochow University), K. Bonatz(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie), Giovanni Barosi(Policlinico San Matteo Fondazione), Amylou C. Dueck(Mayo Clinic in Arizona), Keith Cannon(Mayo Clinic in Arizona), H. Schouten, J Cahn(Centre Hospitalier Universitaire de Grenoble), F. Cervantes(Hospital Clínic de Barcelona), Zhihua Xu(Ministry of Education of the People's Republic of China), Jie Xu(Tianjin Medical University), Martin Grießhammer(Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie)
Haematologica
January 1, 2015
Cited by 2
Related Papers
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial
|Journal of Clinical Oncology|2015|2.6k